Subscribe To
Cassava sciences: my bullish take on biomarkers and ctad data
Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug candidate, but outside research supports its app...
October 30, 2023, 3:30 am
Cassava sciences: why market skepticism persists despite positive findings on simufilam
Cassava Sciences' Alzheimer's drug, simufilam, reduced cognitive decline by 38% in a small study, but t...
July 5, 2023, 3:05 pm
Why shares of cassava sciences are dropping wednesday
simufilam slowed cognitive decline by 38% compared to a placebo after six months for patients with mild...
July 5, 2023, 11:44 am
New publication highlights basic science supporting simufilam
Publication Reviews Certain Receptor-Protein Interactions. Provides Overview of Basic Science Supporting simuf...
June 12, 2023, 1:15 pm
Cassava (sava) up on progress with alzheimers disease study
Cassava (SAVA) made positive progress with simufilam, an oral drug treatment for Alzheimer's disease de...
May 30, 2023, 1:11 pm
Why shares of cassava sciences jumped this week
The company has a small pipeline. Cassava also released data showing that simufilam could be useful as ...
May 12, 2023, 4:39 pm
Insider richard barry is betting big on cassava (sava) stock
Cassava Sciences (NASDAQ: SAVA ) stock rose 11% overnight after director Richard Barry said he bought shares worth $2.3 million. The company is workin...
March 9, 2023, 9:35 am
Cassava sciences stock undervalued with its $124 price target?
Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its ...
January 31, 2023, 2:01 am
Cassava sciences' data once again misunderstood
Cassava Sciences' simufilam staved off cognitive decline in mild Alzheimer's disease. The market reacte...
January 27, 2023, 11:37 am
Anavex's blarcamesine and other disease modifying treatments for alzheimer's disease
Treatments such as Aricept and likely simufilam that inhibit the formation of the nitro-oxidant peroxyn...
September 7, 2022, 3:23 pm
Cassava sciences is a worthwhile bet to consider
FDA approval for simufilam and successful trials of a new blood test to detect Alzheimer's disease coul...
April 25, 2022, 3:11 pm
Anavex's blarcamesine and cassava sciences' simufilam: the stabilization period for alzheimer's disease
Aricept and blarcamesine limit further oxidative stress in Alzheimer's disease via agonism of Sigma-1 receptors. ...
March 22, 2022, 10:16 pm
Does cassava sciences and its alzheimer's drug really have what it takes?
Can Cassava Sciences' simufilam drug really treat Alzheimer's? Who really knows....
February 8, 2022, 5:30 pm
Does cassava sciences and its alzheimer's drug really have what it takes?
Can Cassava Sciences' simufilam drug really treat Alzheimer's? Who really knows....
February 8, 2022, 5:30 pm
Does cassava sciences and its alzheimer's drug really have what it takes?
Can Cassava Sciences' simufilam drug really treat Alzheimer's? Who really knows....
February 8, 2022, 5:30 pm
Cassava sciences starts late-stage simufilam study in alzheimer's patients
Cassava Sciences Inc (NASDAQ: SAVA) initiated an initial Phase 3 efficacy study of simufilam, an inv...
October 6, 2021, 12:31 pm
Cassava sciences starts late-stage simufilam study in alzheimer's patients
Cassava Sciences Inc (NASDAQ: SAVA) initiated an initial Phase 3 efficacy study of simufilam, an inv...
October 6, 2021, 12:31 pm
Cassava sciences starts late-stage simufilam study in alzheimer's patients
Cassava Sciences Inc (NASDAQ: SAVA) initiated an initial Phase 3 efficacy study of simufilam, an inv...
October 6, 2021, 12:31 pm